Skip to main content

Headlines

Alnylam Presents ALN-APP's Updated Positive Interim Phase 1 Results In Alzheimer's Disease, CAA
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
UK regulator refers Adobe's $20 bln buyout of Figma to phase 2 probe
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Genentech : Phase III Trial Of Ocrevus In Multiple Sclerosis Meets Primary And Secondary Endpoints
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
NextDecade makes final investment decision on Rio Grande LNG Phase 1
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AstraZeneca Says Dato-DXd Meets Dual Primary Endpoint Of PFS In Phase III Trial In Lung Cancer
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Ipsen, GENFIT Reveal Positive Phase III Trial Results Of Elafibranor In Patients With PBC
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
SK Reports Positive Results From Phase II Study Of 21-Valent Pneumococcal Conjugate Vaccine
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Cohen's Point72 Boosts Stake in Praxis Precision Medicines Ahead of Phase 3 Trials
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
General Dynamics Granted $769 Mln To Advance To Next Phase Of OMFV Competition
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
AbbVie Announces Positive Results From Phase 1/2 Trial Of Epcoritamab In R/R Follicular Lymphoma
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Astellas :Phase 3 Trial Of Fezolinetant Shows Positive Results For Treatment Of VMS Due To Menopause
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Eli Lilly's Obesity Drug Retatrutide Leads To 24.2% Weight Loss In Phase 2 Trial
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Spain’s election frontrunners plan U-turn in nuclear power phase-out
posted:
by: Nasdaq Commodities
#channels:: #All, #Business, #Nasdaq, #NasdaqCommodities, #Commodities, #Stocks
PainReform's Phase 3 Trial Of PRF-110 Delayed Due To Supplier Issue
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AstraZeneca Reports Positive Results From Interim Analysis Of DESTINY-PanTumor02 Phase II Trial
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets